The success of NIPRO’s biosimilar product, launched in late 2023, has exceeded expectations and gained significant market ...

The Global Smart Syringes Market size is expected to be worth around USD 23.9 billion by 2033 from USD 8.9 billion in 2023, growing at a CAGR of 10.4% ...

Moreover, these devices are used to administer numerous ... In order to prevent cross-contamination, medical experts favor safety syringes. High Growth Potential in Developing Economies Creates ...

Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.

With the safePICO self-fill blood gas syringe, you can improve your mixing and get results you can trust. Mixing ball helps you obtain a homogeneous sample SafeTIPCAP minimizes the risk of blood ...

They contribute to the preservation of patient safety and the reduction of cross-contamination risks. Frequent use of disposable syringes for intravenous or intramuscular administration of drugs to ...

The global vaccine packaging market size to hit USD 3.32 billion by 2033, growing from USD 1.94 billion in 2024, expanding at ...

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Detailed price information for Sharps Technology Inc (STSS-Q) from The Globe and Mail including charting and trades.

NEW YORK - Sharps Technology, Inc. (NASDAQ: STSS), a medical device and pharmaceutical packaging company known for its smart-safety syringe products, has announced the pricing of its public offering ...